Spectrum Pharmaceuticals, Inc.
11500 South Eastern Avenue, Suite 240
Henderson, NV 89052
tel: (702) 835-6300
fax: (702) 260-7405
company website
11500 South Eastern Avenue, Suite 240
Henderson, NV 89052
tel: (702) 835-6300
fax: (702) 260-7405
company website
Redefining Cancer Care
Spectrum Pharmaceuticals, Inc., is a rapidly growing biotechnology company headquartered in Henderson, Nevada. With commercial and clinical development expertise, Spectrum has a record of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products.
Diversified Leader in Hematology/Oncology
Spectrum is a commercial biotechnology company with a diversified revenue stream and a strong pipeline, a rarity in the industry. The company currently markets five cancer drugs, four of them for blood cancers. With several successful approvals and launches in recent years, Spectrum has emerged as a leader in Hematology/Oncology. Many of the drugs that are marketed by Spectrum are used in patients who have little if any other options for the treatment of their disease.
Acquisition and Development Fuels Growth
Spectrum’s commercial success helps the company generate meaningful cash flow, which is used by the company to invest further in the acquisition and development of drugs. Spectrum uses the world as its early stage laboratory and has acquired or in-licensed all the drugs that it commercializes and develops. This risk-reduced business strategy allows Spectrum to focus on adding value to each product acquisition while bringing promising therapeutic agents to patients.
Strong Pipeline
The company has two drugs in late-stage clinical trials and several others in mid- and early stage development. Investigational drugs are being evaluated in several clinical trials, some conducted by Spectrum and others by independent investigators from the oncology community.
Passionate People
The founder, chairman and CEO of the company, Dr. Rajesh Shrotriya, has guided the company since its founding in 2002. Spectrum has attracted seasoned executives from industry-leading pharmaceutical and biotechnology companies who already have experience developing blockbuster drugs. Spectrum’s people have an intense passion for identifying, developing and delivering important options for people suffering from cancer.